Biocells Medical

29/05/2026

BioCells Medical — in China🇨🇳

Last week, our team travelled to China as part of one of our on-site treatment programmes, to administer cell therapy to a patient whose condition did not allow them to travel to our clinic.

When the patient cannot come to us — we come to them. The procedure was performed on site, in full compliance with our treatment protocol and clinical standards.

During this trip, we also visited one of the leading cell therapy centres in China. Our colleagues gave us a tour of the clinic, walked us through their clinical process, and shared their experience in applying cell therapy across the East Asian region.

This meeting marked the beginning of a new partnership — and the first step in BioCells Medical’s expansion in East Asia.
A new chapter begins.

Book your individual consultation

Our medical team will guide you through every stage — from initial assessment to long-term follow-up.

📲 WhatsApp:
+48 453 057 307 (EN / RU / PL)
+39 392 995 4131 (IT)
+33 6 52 10 11 76 (FR)
🌐 biocellsmedical.com

neurorehabilitation medicaltourism celltherapy biocellsinchina eastasiaexpansion internationalmedicine onsitetreatment personalisedmedicine

26/05/2026

At BioCells Medical, all cell processing is performed in-house at our certified Warsaw laboratory, under EU regulatory standards. Every therapy is prepared specifically for the patient who will receive it.

Before any batch is approved for treatment, it must meet strict criteria:
— at least 95% of cells alive and functional, confirmed by flow cytometry;
— sterility verified through 14-day culture testing (Ph. Eur. 2.6.1);
— endotoxin levels below 0.5 EU/ml;
— MSC identity confirmed in line with ISCT criteria;
— biological potency verified through functional assays.

📩 Book your individual consultation to learn more.
📞 WhatsApp:
+48 453 057 307 (EN/RU/PL)
+39 392 995 4131 (IT)
+33 6 52 10 11 76 (FR)
patientsafety celltherapy clinicalexcellence precisionmedicine

23/05/2026

Regenerative medicine is supported by thousands of clinical studies and real patient outcomes worldwide. Protocols, safety standards, and scientific understanding of biological processes have advanced significantly.

What was once called experimental is today precision medicine — capable of stopping the progression of severe neurological and autoimmune diseases.

Book your individual consultation to find out whether cellular therapy is right for you.

WhatsApp:
🇬🇧🇷🇺🇵🇱 +48 453 057 307
🇮🇹 +39 392 995 4131
🇫🇷 +33 6 52 10 11 76

mesenchymalstemcells neurology autoimmune clinicalresearch medicalinnovation BioCellsMedical

23/05/2026

Today, regenerative medicine is backed by thousands of clinical studies and documented protocols across leading clinics worldwide.

Over the past decade:
— protocols have become precise — tailored to specific diagnoses and stages;
— safety standards control every stage of cell processing;
— the mechanisms of cellular therapy are far better understood.
What began as research is now applied as precision medicine — for multiple sclerosis, ALS, ataxia, and Parkinson’s disease.

Each protocol is selected individually.
📩 Book your individual consultation to learn about treatment options for your case.

📞 WhatsApp:
+48 453 057 307 (EN/RU/PL)
+39 392 995 4131 (IT)
+33 6 52 10 11 76 (FR)

als ataxia parkinsons precisionmedicine neurorehabilitation autoimmunedisease

18/05/2026

Medications and cellular therapy operate on fundamentally different principles‼️

A pharmaceutical drug is a stable chemical compound with a single, predefined function. It follows one biochemical pathway — consistent and predictable — regardless of what the tissue actually requires.

A mesenchymal stem cell is a living biological agent. It senses the local environment, migrates toward damaged tissue, and releases a tailored combination of bioactive factors based on what that site needs.

One pathway versus many targets. This adaptive, multi-target mechanism is why cellular therapy can address complex conditions where single-pathway medications have a limited effect.

It is not a replacement for medication — in many cases, the two work together. Only a physician can determine the right strategy for your diagnosis.

Book your individual consultation for a personalised assessment from our medical team.
📞 WhatsApp:
+48 453 057 307 (EN/RU/PL)
+39 392 995 4131 (IT)
+33 6 52 10 11 76 (FR)

neurorehabilitation stemcells innovativemedicine biocellsmedical

14/05/2026

Your immune system may be attacking your brain right now‼️

In MS, ALS and ataxia, chronic neuroinflammation quietly destroys neural tissue — often years before the first symptom appears.

This is exactly what we target at BioCells Medical. Across 288 MS patients, 79% reached functional stabilisation. Across 257 ALS patients — 76%.

These results come from one thing: addressing the inflammation, not just the symptoms.

Book your individual consultation to understand what can be done in your case.

WhatsApp:
🇬🇧🇷🇺🇵🇱 +48 453 057 307
🇮🇹 +39 392 995 4131
🇫🇷 +33 6 52 10 11 76

ataxia MStreatment neurology stemcells MSC brainhealth autoimmune neurodegeneration BioCellsMedical medicalinnovation

14/05/2026

12/05/2026

CONTRAINDICATIONS for stem cell therapy🧬

Stem cell therapy isn’t for everyone.
There are conditions that make cellular therapy impossible — or require postponing it: active malignancy under treatment, uncontrolled systemic infection, decompensated organ failure, certain haematological disorders.

Every case is reviewed individually by our medical board. In some situations — after stabilisation of a concurrent condition or adjustment of current therapy —
re-evaluation becomes possible.

If treatment isn’t feasible right now, we say so at the initial consultation.

✉️ Book your individual consultation with our medical team